Presentation Slides
Back to course
Pdf Summary
long-acting injectable antipsychotics
serious mental illnesses
medication errors
healthcare professionals
specific characteristics
post-injection delirium/sedation syndrome
olanzapine pamoate
Risk Evaluation and Mitigation Strategy
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
Powered By